CervoMed Inc. Deferred Tax Liabilities, Gross
CervoMed Inc. (CRVO) had Deferred Tax Liabilities, Gross of $520.47 thousand as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-13
- 2025-12-31: Deferred Tax Liabilities, Gross $520.47K.
- 2024-12-31: Deferred Tax Liabilities, Gross $373.94K.
- 2023-12-31: Deferred Tax Liabilities, Gross $166.66K.
- 2022-12-31: Deferred Tax Liabilities, Gross $0.00.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $520.47K 10-K · filed 2026-03-13 |
| 2024-12-31 | $373.94K 10-K · filed 2026-03-13 |
| 2023-12-31 | $166.66K 10-K · filed 2025-03-17 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-29 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2020-12-31 | $2.26M 10-K · filed 2022-03-18 |
| 2019-12-31 | $2.29M 10-K · filed 2021-03-17 |
| 2018-12-31 | $2.22M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |